[1] AD P, RF W, SA R. Basic science of articular cartilage and osteoarthritis [J]. Clinics in sports medicine, 2005, 24(1): 1-12.
[2] TW O N, PS M, J M. Update on the epidemiology, risk factors and disease outcomes of osteoarthritis [J]. Best practice & research Clinical rheumatology, 2018, 32(2): 312-26.
[3] ZHANG Y, JORDAN J M. Epidemiology of osteoarthritis [J]. Rheumatic Disease Clinics of North America, 2008, 34(3): 515-29.
[4] PEREIRA D, PELETEIRO B, ARA ºJO J, et al. The effect of osteoarthritis definition on prevalence and incidence estimates: a systematic review [J]. Osteoarthritis Cartilage, 2011, 19(11): 1270-85.
[5] FELSON D T, NAIMARK A, ANDERSON J, et al. The prevalence of knee osteoarthritis in the elderly. the Framingham osteoarthritis study [J]. Arthritis & Rheumatology, 2014, 30(8): 914-8.
[6] RF L. Aging and osteoarthritis [J]. Current opinion in rheumatology, 2011, 23(5): 492-6.
[7] LORIES R J, LUYTEN F P. The bone-cartilage unit in osteoarthritis [J]. Nature Reviews Rheumatology, 2011, 7(1): 43.
[8] TCHETINA E V. Developmental mechanisms in articular cartilage degradation in osteoarthritis [J]. Arthritis,2011,(2010-12-15), 2010, 2011(2090-1984): 683970.
[9] TCHETINA E V. Developmental mechanisms in articular cartilage degradation in osteoarthritis [J]. Arthritis, 2010, 2011(2090-1984): 683970.
[10] DREIER R. Hypertrophic differentiation of chondrocytes in osteoarthritis: the developmental aspect of degenerative joint disorders [J]. Arthritis Research & Therapy, 2010, 12(5): 1-11.
[11] ARTHROSCOPY. Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA [J].
[12] VAN D K P M, MARIE-JOS G, ESMERALDA B D, et al. Age-dependent alteration of TGF-β signalling in osteoarthritis [J]. Cell & Tissue Research, 2012, 347(1): 257-65.
[13] BLANEY DAVIDSON E N, REMST D F, VITTERS E L, et al. Increase in ALK1/ALK5 ratio as a cause for elevated MMP-13 expression in osteoarthritis in humans and mice [J]. Journal of Immunology, 2009, 182(12): 7937-45.
[14] A V C, W M, A G D V, et al. TGFβ1-induced SMAD2/3 and SMAD1/5 phosphorylation are both ALK5-kinase-dependent in primary chondrocytes and mediated by TAK1 kinase activity [J]. Arthritis research & therapy, 2017, 19(1): 112.
[15] RD C, G C, J P, et al. SOX9 protein is stabilized by TGF-β and regulates PAPSS2 mRNA expression in chondrocytes [J]. Osteoarthritis and cartilage, 2017, 25(2): 332-40.
[16] FANG J, XU L, LI Y, et al. Roles of TGF-beta 1 signaling in the development of osteoarthritis [J]. Histology & Histopathology, 2016, 31(11): 11779.
[17] VALDES A M, SPECTOR T D, TAMM A, et al. Genetic variation in the SMAD3 gene is associated with hip and knee osteoarthritis [J]. Arthritis & Rheumatism, 2014, 62(8): 2347-52.
[18] P B, X C, PS F, et al. The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine [J]. Nature medicine, 2013, 19(1): 35-42.
[19] S M-F, TV M, F F, et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche [J]. Nature, 2010, 466(7308): 829-34.
[20] K N, X Z, G K, et al. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation [J]. Cell, 2002, 108(1): 17-29.
[21] ZHEN G, WEN C, JIA X, et al. Inhibition of TGF-[beta] signaling in mesenchymal stem cells of subchondral bone attenuates osteoarthritis [J]. Nature Medicine, 2016, 19(6): 704-12.
[22] SHARKEY P F, COHEN S B, LEINBERRY C F, et al. Subchondral bone marrow lesions associated with knee osteoarthritis [J]. American Journal of Orthopedics, 2012, 41(9): 413-7.
[23] HENROTIN Y, PESESSE L, SANCHEZ C. Subchondral bone and osteoarthritis: biological and cellular aspects [J]. Osteoporosis International, 2012, 23(8): 847-51.
[24] CUI Z, CRANE J, XIE H, et al. Halofuginone attenuates osteoarthritis by inhibition of TGF-β activity and H-type vessel formation in subchondral bone [J]. Annals of the Rheumatic Diseases, 2016, 75(9): 1714-21.
[25] KEYAK J H. Relationships between femoral fracture loads for two load configurations [J]. Journal of Biomechanics, 2000, 33(4): 499-502.
[26] KELLGREN J H, LAWRENCE J S. Radiological assessment of osteo-arthrosis [J]. Ann Rheum Dis, 1957, 16(4): 494-502.
[27] RADIN E L, ROSE R M. Role of subchondral bone in the initiation and progression of cartilage damage [J]. Clin Orthop Relat Res, 1986, 213(213): 34-40.
[28] KRAAN P M, VAN DER, MARIE-JOS G, ESMERALDA B D, et al. Age-dependent alteration of TGF-β signalling in osteoarthritis [J]. Cell & Tissue Research, 2012, 347(1): 257-65.
[29] DAVIDSON E N, BLANEY, REMST D F G, VITTERS E L, et al. Increase in ALK1/ALK5 ratio as a cause for elevated MMP-13 expression in osteoarthritis in humans and mice [J]. Journal of Immunology, 2009, 182(12): 7937-45.
[30] SHEN J, LI S, CHEN D. TGF-β signaling and the development of osteoarthritis [J]. Bone Research, 2014, 2(2): 73-9.
[31] CRANE J L, XU C. Bone marrow mesenchymal stem cells and TGF-β signaling in bone remodeling [J]. Journal of Clinical Investigation, 2014, 124(2): 466-72.
[32] YUAN X L, MENG H Y, WANG Y C, et al. Bone–cartilage interface crosstalk in osteoarthritis: potential pathways and future therapeutic strategies [J]. Osteoarthritis & Cartilage, 2014, 22(8): 1077-89.
[33] ZHEN G, WEN C, JIA X, et al. Inhibition of TGF–β signaling in subchondral bone mesenchymal stem cells attenuates osteoarthritis [J]. Nature Medicine, 2013, 19(6): 704-12.
[34] WANG W, LI C, PANG L, et al. Mesenchymal stem cells recruited by active TGFβ contribute to osteogenic vascular calcification [J]. Stem Cells & Development, 2014, 23(12): 1392-404.
[35] SHEN J, LI J, WANG B, et al. Deletion of the Transforming Growth Factor β Receptor Type II Gene in Articular Chondrocytes Leads to a Progressive Osteoarthritis‐like Phenotype in Mice [J]. Arthritis & Rheumatism, 2013, 65(12): 3107-19.
[36] GUEDERS M M, FOIDART J M, NOEL A, et al. Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: Potential implications in asthma and other lung diseases [J]. European Journal of Pharmacology, 2006, 533(1-3): 133-44.
[37] PENGAS I, ELDRIDGE S, ASSIOTIS A, et al. MMP-3 in the peripheral serum as a biomarker of knee osteoarthritis, 40 years after open total knee meniscectomy [J]. Journal of Experimental Orthopaedics, 2018, 5(1): 21.
[38] BURRAGE P S, MIX K S, BRINCKERHOFF C E. Matrix metalloproteinases: role in arthritis [J]. Front Biosci, 2006, 11(1): 529-43.
[39] PENGCUI L, JIN D, XIAOCHUN W, et al. Blockade of hypoxia-induced CXCR4 with AMD3100 inhibits production of OA-associated catabolic mediators IL-1β and MMP-13 [J]. Molecular Medicine Reports, 2016, 14(2): 1475-82.
[40] WANG M, SAMPSON E R, JIN H, et al. MMP13 is a critical target gene during the progression of osteoarthritis [J]. Arthritis Res Ther, 2013, 15(1): R5.
[41] LIM N H, MEINJOHANNS E, MELDAL M, et al. In vivo imaging of MMP-13 activity in the murine destabilised medial meniscus surgical model of osteoarthritis [J]. Osteoarthritis & Cartilage, 2014, 22(6): 862-8.
[42] LI H, WANG D, YUAN Y, et al. New insights on the MMP-13 regulatory network in the pathogenesis of early osteoarthritis [J]. Arthritis Research & Therapy, 2017, 19(1): 248.
[43] TOMOO S, KOJI K, SATOSHI Y, et al. Comparative analysis of gene expression profiles in intact and damaged regions of human osteoarthritic cartilage [J]. Arthritis and rheumatism, 2010, 54(3): 808-17.
[44] CHEN Y T, HOU C H, HOU S M, et al. The Effects of Amphiregulin Induced MMP-13 Production in Human Osteoarthritis Synovial Fibroblast [J]. Mediators Inflamm, 2014, 2014(6): 759028.
[45] HUANG X, PAN Q, MAO Z, et al. Kaempferol inhibits interleukin‑1β stimulated matrix metalloproteinases by suppressing the MAPK‑associated ERK and P38 signaling pathways [J]. Molecular Medicine Reports, 2018,
[46] FAN Z, S ¶DER S, OEHLER S, et al. Activation of interleukin-1 signaling cascades in normal and osteoarthritic articular cartilage [J]. American Journal of Pathology, 2007, 171(3): 938-46.
[47] MARTIN T J. Parathyroid Hormone-Related Protein, Its Regulation of Cartilage and Bone Development, and Role in Treating Bone Diseases [J]. Physiological reviews, 2016, 96(3): 831-71.
[48] LI C, WANG W, XIE L, et al. Lipoprotein receptor-related protein 6 is required for parathyroid hormone-induced Sost suppression [J]. Annals of the New York Academy of Sciences, 2016, 1364(1): 62-73.
[49] MAES C, KRONENBERG H M. Bone development and remodeling [J]. Bioessays News & Reviews in Molecular Cellular & Developmental Biology, 2014, 6(4): 171–5.
[50] A P, L C, A N, et al. A review of hedgehog signaling in cranial bone development [J]. Frontiers in physiology, 2013, 4(undefined): 61.
[51] JINGMING Z, QIAN C, BEATE L, et al. Disrupting the Indian hedgehog signaling pathway in vivo attenuates surgically induced osteoarthritis progression in Col2a1-CreERT2; Ihhfl/fl mice [J]. Arthritis Research & Therapy, 2014, 16(1): R11.
[52] K S, A L, C Z, et al. Hedgehog signaling restrains bladder cancer progression by eliciting stromal production of urothelial differentiation factors [J]. Cancer cell, 2014, 26(4): 521-33.
[53] MC K, AL J, CA L, et al. Sonic hedgehog signaling in the lung. From development to disease [J]. American journal of respiratory cell and molecular biology, 2015, 52(1): 1-13.
[54] X X, Y L, Y L, et al. Sonic Hedgehog Signaling in Thyroid Cancer [J]. Frontiers in endocrinology, 2017, 8(undefined): 284.
[55] R Y, T Y, JA W, et al. Wnt/beta-catenin and retinoic acid receptor signaling pathways interact to regulate chondrocyte function and matrix turnover [J]. The Journal of biological chemistry, 2010, 285(1): 317-27.
[56] T Y, T O, T K, et al. Wnt/beta-catenin signaling stimulates matrix catabolic genes and activity in articular chondrocytes: its possible role in joint degeneration [J]. Laboratory investigation; a journal of technical methods and pathology, 2008, 88(3): 264-74.
[57] M Z, D T, Q W, et al. Activation of beta-catenin signaling in articular chondrocytes leads to osteoarthritis-like phenotype in adult beta-catenin conditional activation mice [J]. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2009, 24(1): 12-21.
[58] J S, J L, B W, et al. Deletion of the transforming growth factor β receptor type II gene in articular chondrocytes leads to a progressive osteoarthritis-like phenotype in mice [J]. Arthritis and rheumatism, 2013, 65(12): 3107-19.
[59] EN B D, DF R, EL V, et al. Increase in ALK1/ALK5 ratio as a cause for elevated MMP-13 expression in osteoarthritis in humans and mice [J]. Journal of immunology (Baltimore, Md : 1950), 2009, 182(12): 7937-45.
[60] PM V D K, MJ G, E B D, et al. Age-dependent alteration of TGF-β signalling in osteoarthritis [J]. Cell and tissue research, 2012, 347(1): 257-65.
[61] ZAIDI M. Skeletal remodeling in health and disease [J]. Nature Medicine, 2007, 13(7): 791-801.
[62] MUNDY G R, FLORENT E. Boning up on ephrin signaling [J]. Cell, 2006, 126(3): 441-3.
[63] HADJIDAKIS D J, ANDROULAKIS I I. Bone Remodeling [J]. Annals of the New York Academy of Sciences, 2006, 1092(1): 385–96.
[64] CRANE J L, XIAN L, CAO X. Role of TGF-β Signaling in Coupling Bone Remodeling [J]. Methods in Molecular Biology, 2016, 1344(287.
[65] TANG Y, WU X W. TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation [J]. Nature Medicine, 2009, 15(7): 757-65.